Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
amyloidosis
Marketing
Alnylam embarks on campaign to drive hATTR amyloidosis diagnoses
Alnylam's new campaign encourages people to talk about their family health history in hopes of identifying hereditary diseases they may be carrying.
Andrea Park
Mar 13, 2024 10:30am
FDA signs off on Ionis, AZ's rare disease drug Wainua
Dec 22, 2023 8:45am
Ionis lays off majority of Akcea staff, expands deal with Sobi
Apr 7, 2021 11:42am
J&J's Darzalex branches out beyond myeloma with amyloidosis win
Jun 13, 2020 2:30am
Takeda details Ninlaro's miss in AL amyloidosis
Dec 9, 2019 3:41am
NICE U-turn puts Alnylam's Onpattro back in the game with Ionis
Jul 9, 2019 11:18am
